Ayurveda vs Biologics for Psoriasis: Cost, Results, and Which to Choose
Choosing between Ayurveda and biologic therapy is one of the most consequential decisions a psoriasis patient makes, and it deserves a genuinely honest comparison rather than a sales pitch for either side. This guide lays out exactly what each approach costs, what results are actually documented for each, and a practical framework for deciding what’s right for your specific situation.
(This article draws on our detailed guides to psoriasis treatment cost in India, side effects of psoriasis treatments, and psoriasis treatment options.)
Understanding the Two Approaches
Before comparing cost and results, it’s worth understanding how fundamentally differently these two systems approach the same disease.
How Biologics Work
Biologics are laboratory-engineered proteins that target one specific inflammatory messenger, most commonly TNF-alpha, IL-17, or IL-23, discussed throughout our inflammation and psoriasis guide. By blocking one precise link in the inflammatory chain, they interrupt the immune signaling that drives visible plaques, generally without broadly suppressing the entire immune system the way older systemic drugs do.
How Ayurveda Works
Ayurveda approaches psoriasis as a whole-body expression of dosha imbalance, most closely correlated with the classical condition Kushta, involving Vata, Pitta, and Kapha dosha alongside weakened digestive fire (Agni) and accumulated toxins (Ama). Rather than targeting a single inflammatory messenger, treatment combines internal medicines, purification therapy (Shodhana) where appropriate, external applications, and structured diet and lifestyle correction, aimed at correcting the underlying systemic pattern believed to produce the visible disease.
Results: What the Evidence Actually Shows
This is the section where honesty matters most, since the two systems have been evaluated through genuinely different kinds of evidence, and presenting that difference clearly is more useful to you than pretending it doesn’t exist.
Biologic Results: Large-Scale Trial Data
Biologics have been tested in some of the largest, most rigorously controlled trials in all of dermatology, and the results are genuinely strong. A comprehensive network meta-analysis of 71 randomized controlled trials found short-term PASI 90 response rates of 72.9% for ixekizumab, 72.5% for risankizumab, and 72.0% for brodalumab, meaning roughly three in four patients achieved 90% or greater skin clearance within the trial period.
Long-term data is, if anything, even more encouraging for top-performing agents. The same analysis found risankizumab reaching an 85.3% PASI 90 rate with longer-term use, and real-world cohort data outside the controlled trial setting has shown similarly strong results: one large multicenter study found 83% of patients achieved PASI 90 and 45% achieved complete PASI 100 clearance on biologic therapy, broadly consistent with published trial results.
Ayurvedic Results: Documented Case Reports
Ayurvedic outcomes for psoriasis come from a genuinely different evidentiary tradition: individually documented, peer-reviewed case reports rather than large randomized trials. These reports are real and published, and several show meaningful, objectively measured improvement using the same PASI scoring system used in biologic trials.
One published case documented a patient’s PASI score falling from 21.8 to 0.8 following Shamana chikitsa; another documented a reduction from 32 to 0.6 following combined Shamana treatment and Nitya virechana, with no recurrence reported four months after treatment ended. Case reports specifically addressing psoriatic arthritis, covered in our Ayurvedic treatment for psoriatic arthritis guide, have documented similarly meaningful improvement, including measurable reductions in inflammatory markers like ESR.
Why These Two Evidence Bases Aren’t Directly Comparable
It would be misleading to place a handful of case reports next to network meta-analyses of dozens of trials and claim equivalent certainty; they simply aren’t the same kind of evidence. What the Ayurvedic case literature does demonstrate is genuine, individually documented, PASI-measured improvement in real patients treated with an individualized protocol, including some who had already tried and not responded well to conventional treatment.
This is precisely why Ayurveda is best evaluated on its own terms: as a system built around the individual patient in front of the physician, factoring in constitution, digestive strength, disease stage, and personal triggers, rather than a single fixed protocol tested identically across a large trial population. The growing case-report record reflects exactly this kind of careful, individualized clinical documentation, even as it continues to expand year over year.
Cost Comparison: A Genuinely Large Gap
Cost is often the single deciding factor for Indian patients, and the gap between these two approaches is substantial and worth understanding in concrete numbers.
Biologic Costs
As detailed in our psoriasis treatment cost in India guide, biologic therapy in India typically ranges from roughly ₹70,000 per month to several lakh rupees for a treatment course, depending on the specific drug and whether a biosimilar or originator product is used. This is not a one-time cost; biologics generally need to be continued indefinitely to maintain results, meaning this expense recurs monthly or every few months for as long as treatment continues.
Insurance coverage, discussed in depth in our guide to insurance coverage for psoriasis treatment in India, often doesn’t fully close this gap either, since many policies don’t cover routine outpatient biologic administration without specific riders or day-care classification.
Ayurvedic Treatment Costs
Ayurvedic treatment costs considerably less on a recurring basis: typically ₹1,000 to ₹5,000 per month for internal medicines, with a complete Panchakarma purification package, where appropriate, costing roughly ₹10,000 to ₹50,000 as a more substantial but generally one-time or infrequent investment. Even accounting for an initial purification course, the total first-year cost of Ayurvedic treatment is usually a small fraction of a single year of biologic therapy.
What This Cost Difference Actually Means in Practice
This isn’t simply “cheaper is better” or “more expensive is more effective”; it reflects two genuinely different treatment philosophies and cost structures. Biologic pricing reflects the cost of producing complex, laboratory-engineered proteins and the rigorous trial process behind them, while Ayurvedic treatment costs reflect a more accessible, longer-established production and practice model, and the difference matters most for patients making an honest, practical decision about what’s sustainable for their own household budget over years, not months.
Long-Term Considerations Beyond Initial Cost and Results
A genuinely complete comparison needs to look past the first course of treatment, since psoriasis is a lifelong, relapsing condition regardless of which approach you choose.
The Biologic Long-Term Picture
Biologics generally require ongoing, indefinite use to maintain results, since stopping treatment typically leads to gradual return of symptoms. As discussed in our side effects of psoriasis treatments guide, this means committing to years of regular injections or infusions, ongoing safety monitoring, including infection screening and periodic bloodwork, and the real possibility of secondary loss of response over time, sometimes requiring a switch to a different biologic.
The Ayurvedic Long-Term Picture
Ayurvedic treatment follows a different long-term logic: an initial, more intensive treatment phase, often several months, aimed at correcting the underlying imbalance, followed by a maintenance and prevention phase focused on diet, lifestyle, and periodic rejuvenation therapy (Rasayana) rather than indefinite, unchanged medication. Case reports have documented sustained improvement even after treatment concluded, though as with any chronic condition, ongoing attention to personal triggers remains important for lasting results.
Safety Profiles Over Time
Both approaches carry genuine, documented safety considerations worth weighing over a multi-year horizon. Biologics carry class-specific risks discussed in our side effects guide, including infection susceptibility and, for certain classes, more actively debated long-term signals; herbal Ayurvedic formulations, discussed in our ashwagandha for psoriasis coverage, are not automatically risk-free either, and quality sourcing and qualified practitioner supervision matter just as much as with any other treatment system.
When Biologic Therapy Is Genuinely the Right Choice
There are situations where prompt, strong disease control matters more than any other consideration, and it’s important to say this plainly rather than let a cost or philosophy preference override it.
Severe, rapidly progressing psoriasis, or psoriatic arthritis with active joint inflammation, benefits from fast, powerful disease control, since delayed treatment of joint disease can allow irreversible damage to accumulate, discussed in depth in our psoriatic arthritis guide. In these situations, the strong, well-documented trial evidence behind biologics represents a genuinely important, sometimes time-critical, treatment option worth taking seriously.
This doesn’t mean Ayurveda has no role in these cases; many patients successfully combine both approaches, discussed further below, but severe or rapidly worsening disease is not the situation to delay effective, evidence-strong treatment while deciding between systems.
When Ayurvedic Treatment Is a Strong, Reasonable Choice
For a large proportion of patients, particularly those with mild to moderate, more stable disease, Ayurveda offers a genuinely compelling combination of documented improvement, dramatically lower cost, and a whole-body, individualized approach that many patients find better suited to their goals and values.
Patients specifically seeking a non-steroidal, longer-term management philosophy, those whose disease has plateaued or relapsed despite conventional treatment, or those for whom the ongoing cost of biologic therapy simply isn’t sustainable, all have genuine, evidence-supported reasons to pursue Ayurvedic care as their primary approach, guided by an experienced practitioner who assesses their individual constitution and disease stage directly.
Can Ayurveda and Biologics Be Combined?
Yes, and this is more common in practice than many patients realize. Many patients reasonably use biologic therapy for the joints or skin areas where rapid, strong control matters most, while incorporating Ayurvedic dietary guidance, stress management, and supportive external care to address broader trigger management and quality of life.
This combined approach requires genuine transparency with both your dermatologist and Ayurvedic practitioner, since some herbal formulations carry real interaction considerations with immunosuppressive biologic therapy, discussed in our ashwagandha guide. Done thoughtfully, with both providers fully informed, combining approaches lets patients draw on the specific strengths of each system rather than treating the choice as strictly either-or.
A Practical Framework for Deciding
Bringing together everything covered in this guide, a few clear questions can help you and your treating practitioner reach a decision genuinely suited to your situation.
How severe and how fast-moving is your disease right now? Severe, rapidly progressing skin disease or active joint inflammation generally favors starting with, or at least including, biologic therapy for prompt control, given the real risk of irreversible joint damage discussed throughout our psoriatic arthritis content.
What can you realistically sustain financially, year over year? Given the recurring, often lifelong nature of biologic therapy, an honest assessment of long-term affordability, alongside your actual insurance coverage, matters more than the cost of a single month or course.
How do you weigh a whole-body, root-cause philosophy against a targeted, single-pathway approach? This is a genuine, legitimate values question, not just a clinical one, and it’s worth being honest with yourself about which philosophy you find more compelling and sustainable to commit to over years.
Have you already tried one approach without the results you hoped for? Prior treatment history, whether conventional treatment that produced only partial or temporary relief, or Ayurvedic care that wasn’t given a full, properly sequenced course, is genuinely relevant information for your next decision.
Would a combined approach serve you better than choosing exclusively? As discussed above, this isn’t always a binary choice, and many patients find real value in thoughtfully combining both systems under transparent, coordinated care. (For a full walkthrough of how these choices fit into psoriasis treatment more broadly, see our complete guide to psoriasis treatment options.)
Our Approach at Psoriasis Treatment Bangalore
At Psoriasis Treatment Bangalore, we specialize specifically in individualized Ayurvedic care, guided by over two decades of clinical experience under Dr. Chaithanya KS. For patients whose disease is mild to moderate, or who are seeking a sustainable, whole-body, non-steroidal approach, we believe this individualized system offers genuine, well-documented value, reflected in the published case literature discussed throughout this guide.
For patients with severe or rapidly progressing disease, we believe in transparent, honest guidance, including recognizing when prompt conventional evaluation matters most, and we’re glad to discuss how Ayurvedic care can work alongside conventional treatment where that combination genuinely serves you best. Book a consultation today for an individualized assessment of your specific situation. (Explore our complete guide to Ayurvedic psoriasis treatment in India to learn more about our approach.)
Frequently Asked Questions
1. Is Ayurveda as effective as biologics for psoriasis?
The evidence bases aren’t directly comparable: biologics have been tested in dozens of large randomized trials with consistently strong PASI 90 response rates, while Ayurvedic evidence comes from individually documented case reports showing genuine, sometimes similarly dramatic, PASI improvement. Both represent real, documented improvement, but at different levels of scientific certainty, and the right choice depends on your specific severity, goals, and values.
2. How much cheaper is Ayurvedic treatment than biologics?
Considerably cheaper on a recurring basis: Ayurvedic treatment typically costs ₹1,000 to ₹5,000 per month, compared to roughly ₹70,000 per month or more for biologic therapy, which also generally needs to continue indefinitely rather than being a one-time cost.
3. Can I switch from biologics to Ayurveda, or vice versa?
Yes, patients do switch between and combine both approaches, but any transition, especially stopping a biologic, should be done in consultation with your treating physician, given the possibility of rebound flares and the importance of a properly sequenced transition plan.
4. Which approach works faster?
Biologics generally produce faster visible results, with meaningful improvement often seen within weeks. Ayurvedic treatment typically follows a more gradual timeline, often requiring several months for significant improvement, reflecting its whole-body, root-cause approach rather than direct cytokine blockade.
5. Is it safe to combine Ayurvedic and biologic treatment?
Many patients do combine both, but this requires full transparency with both your dermatologist and Ayurvedic practitioner, since certain herbal formulations carry genuine interaction considerations with immunosuppressive biologic therapy.
6. Does insurance cover either option?
Coverage varies considerably for both. Biologics are sometimes covered under comprehensive policies with day-care classification, while Ayurvedic treatment is increasingly covered under IRDAI’s AYUSH mandate for inpatient or day-care procedures, though routine outpatient care of either type is often not covered without a specific rider.
7. What happens if I stop biologic treatment?
Symptoms generally return gradually after stopping, since biologics don’t cure the underlying disease, they suppress the specific inflammatory pathway driving it. This is part of why biologic therapy is typically considered a long-term, ongoing commitment rather than a finite course.
8. Is Ayurvedic treatment appropriate for severe psoriasis?
It can play a role, but severe, rapidly progressing disease, or active psoriatic arthritis with joint involvement, generally benefits from including fast-acting, strongly evidenced treatment like biologics, given the real risk of irreversible joint damage from delay. Ayurveda can still play a valuable supportive or long-term maintenance role in these cases, ideally as part of a coordinated plan.
9. How is Ayurvedic treatment personalized compared to biologic selection?
Biologic selection is generally based on disease pattern, comorbidities, and prior treatment response within a relatively standardized set of drug options. Ayurvedic treatment personalization goes further, incorporating individual constitution (Prakriti), digestive strength, and disease stage into the specific combination of formulations and therapies used.
10. How do I decide which approach is right for me?
Consider your current disease severity and how quickly it’s progressing, what you can realistically sustain financially over years, whether you’ve already tried one approach without success, and whether a combined approach might serve you better than choosing exclusively. Discussing these factors directly with a qualified practitioner, ideally one familiar with both systems, gives you the most personalized answer.
Sources and References
- “Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis,” Dermatology and Therapy, Springer Nature, 2021.
- “Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis Using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort,” PMC.
- “Predictors of PASI90 Response in Patients With Psoriasis Treated With Interleukin Inhibitors: Observational Cohort Study,” PMC.
- “Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules,” PMC.
- “Ayurvedic Management of Ekakushtha (Psoriasis): A Case Study,” Journal of Ayurveda Case Reports, 2023.
- “Management of Scalp Psoriasis Through Ayurvedic Modalities – Case Report,” International Journal of Ayurvedic Medicine, 2024.
- “Ayurvedic Management of Psoriatic Arthritis With Dactylitis – A Case Report,” ScienceDirect, 2025.
- “Ayurvedic Management of Psoriatic Arthritis (Vatarakta),” AYUSHDHARA, 2026.
This article is intended for general educational purposes and does not replace personalized medical advice. Treatment decisions, particularly for severe or rapidly progressing psoriasis or psoriatic arthritis, should be made in consultation with qualified practitioners familiar with your complete health history.
